Citius Pharmaceuticals, Inc. (CTXR)
Largest Insider Buys in Sector
CTXR Stock Price History Chart
CTXR Stock Performance
About Citius Pharmaceuticals, Inc.
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of critical care products focusing on anti-infective products in adjunct cancer care, prescription products, and mesenchymal stem cell therapy. The company is developing five proprietary products comprising Mino-Lok, an antibiotic lock solution to treat patients with catheter-related bloodstream infections by salvaging the infected catheter; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections …
Insider Activity of Citius Pharmaceuticals, Inc.
Over the last 12 months, insiders at Citius Pharmaceuticals, Inc. have bought $0 and sold $0 worth of Citius Pharmaceuticals, Inc. stock.
On average, over the past 5 years, insiders at Citius Pharmaceuticals, Inc. have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,234,700 shares for transaction amount of $2M was made by Mazur Leonard L (Executive Chairman) on 2019‑09‑27.
List of Insider Buy and Sell Transactions, Citius Pharmaceuticals, Inc.
| 2019-09-27 | Executive Chairman | 2.23M 13.7793% | $0.90 | $2M | +20.83% | |||
| 2019-09-27 | President and CEO | 558,597 3.4443% | $0.90 | $500,000 | +20.83% | |||
| 2019-04-03 | Executive Chairman | 1.17M 6.2256% | $1.54 | $1.8M | -23.74% | |||
| 2019-04-03 | President and CEO | 129,450 0.6917% | $1.54 | $200,000 | -23.74% | |||
| 2018-08-13 | Executive Chairman | 3.14M 27.0206% | $1.27 | $4M | -14.07% | |||
| 2018-08-13 | President and CEO | 784,314 6.7551% | $1.27 | $1M | -14.07% | |||
| 2018-03-29 | Executive Chairman | 167,504 1.6135% | $2.98 | $499,999 | -51.29% | |||
| 2018-03-28 | President and CEO | 2,915 0.0277% | $3.09 | $9,007 | -53.54% | |||
| 2017-12-19 | Executive Chairman | 213,106 2.6762% | $4.69 | $999,467 | -41.71% | |||
| 2017-08-24 | Executive Chairman | 11,000 0.2205% | $2.68 | $29,480 | +15.56% | |||
| 2017-08-08 | Executive Chairman | 421,400 11.6995% | $4.13 | $1.74M | +4.00% | |||
| 2016-03-30 | director | 10M 6.4441% | $0.60 | $6M | -74.92% |
Insider Historical Profitability
| Mazur Leonard L | Executive Chairman | 10255343 5.6746% | $0.52 | 8 | 0 | <0.0001% |
| HOLUBIAK MYRON Z | President and CEO | 1992243 1.1024% | $0.52 | 4 | 0 | <0.0001% |
Institutional Investor Ownership
| BlackRock | $7.83M | 4.83 | 8.73M | +3.18% | +$241,085.63 | <0.0001 | |
| The Vanguard Group | $6.29M | 3.88 | 7.01M | +1.52% | +$94,116.91 | <0.0001 | |
| Geode Capital Management | $2.64M | 1.63 | 2.95M | +5.96% | +$148,599.28 | <0.0001 | |
| State Street | $1.98M | 1.22 | 2.21M | +0.1% | +$1,976.75 | <0.0001 | |
| Northern Trust | $1.01M | 0.62 | 1.12M | +7.19% | +$67,435.73 | <0.0001 |